Datasets:

Modalities:
Text
Formats:
parquet
Languages:
Spanish
License:
gonzalo-santamaria-iic commited on
Commit
ad84e72
·
verified ·
1 Parent(s): cace189

Update README.md

Browse files
Files changed (1) hide show
  1. README.md +119 -0
README.md CHANGED
@@ -39,4 +39,123 @@ configs:
39
  path: data/validation-*
40
  - split: test
41
  path: data/test-*
 
 
 
 
 
 
 
 
 
42
  ---
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
39
  path: data/validation-*
40
  - split: test
41
  path: data/test-*
42
+ license: cc-by-4.0
43
+ language:
44
+ - es
45
+ multilinguality:
46
+ - monolingual
47
+ task_categories:
48
+ - token-classification
49
+ task_ids:
50
+ - named-entity-recognition
51
  ---
52
+
53
+ # CT-EBM-SP (Clinical Trials for Evidence-based Medicine in Spanish)
54
+
55
+ ## Table of Contents
56
+ - [Table of Contents](#table-of-contents)
57
+ - [Dataset Description](#dataset-description)
58
+ - [Dataset Summary](#dataset-summary)
59
+ - [Supported Tasks and Leaderboards](#supported-tasks-and-leaderboards)
60
+ - [Languages](#languages)
61
+ - [Dataset Structure](#dataset-structure)
62
+ - [Data Instances](#data-instances)
63
+ - [Data Fields](#data-fields)
64
+ - [Data Splits](#data-splits)
65
+ - [Dataset Creation](#dataset-creation)
66
+ - [Curation Rationale](#curation-rationale)
67
+ - [Source Data](#source-data)
68
+ - [Annotations](#annotations)
69
+ - [Personal and Sensitive Information](#personal-and-sensitive-information)
70
+ - [Considerations for Using the Data](#considerations-for-using-the-data)
71
+ - [Social Impact of Dataset](#social-impact-of-dataset)
72
+ - [Discussion of Biases](#discussion-of-biases)
73
+ - [Other Known Limitations](#other-known-limitations)
74
+ - [Additional Information](#additional-information)
75
+ - [Dataset Curators](#dataset-curators)
76
+ - [Licensing Information](#licensing-information)
77
+ - [Citation Information](#citation-information)
78
+ - [Contributions](#contributions)
79
+
80
+ ## Dataset Description
81
+
82
+ - **Homepage:** http://www.lllf.uam.es/ESP/nlpmedterm_en.html
83
+ - **Repository:** http://www.lllf.uam.es/ESP/nlpdata/wp2/CT-EBM-SP.zip
84
+ - **Paper:** Campillos-Llanos, L., Valverde-Mateos, A., Capllonch-Carrión, A., & Moreno-Sandoval, A. (2021). A clinical trials corpus annotated with UMLS entities to enhance the access to evidence-based medicine. BMC medical informatics and decision making, 21(1), 1-19
85
+ - **Point of Contact:** leonardo.campillos AT gmail.com
86
+
87
+ ### Dataset Summary
88
+
89
+ The [Clinical Trials for Evidence-Based-Medicine in Spanish corpus](http://www.lllf.uam.es/ESP/nlpdata/wp2/) is a collection of 1200 texts about clinical trials studies and clinical trials announcements:
90
+ - 500 abstracts from journals published under a Creative Commons license, e.g. available in PubMed or the Scientific Electronic Library Online (SciELO)
91
+ - 700 clinical trials announcements published in the European Clinical Trials Register and Repositorio Español de Estudios Clínicos
92
+
93
+ If you use the CT-EBM-SP resource, please, cite as follows:
94
+
95
+ ```
96
+ @article{campillosetal-midm2021,
97
+         title = {A clinical trials corpus annotated with UMLS© entities to enhance the access to Evidence-Based Medicine},
98
+         author = {Campillos-Llanos, Leonardo and Valverde-Mateos, Ana and Capllonch-Carri{\'o}n, Adri{\'a}n and Moreno-Sandoval, Antonio},
99
+         journal = {BMC Medical Informatics and Decision Making},
100
+         volume={21},
101
+ number={1},
102
+ pages={1--19},
103
+ year={2021},
104
+ publisher={BioMed Central}
105
+ }
106
+ ```
107
+
108
+ ### Supported Tasks
109
+
110
+ Medical Named Entity Recognition
111
+
112
+ ### Languages
113
+
114
+ Spanish
115
+
116
+ ## Dataset Structure
117
+
118
+ ### Data Instances
119
+ - 292 173 tokens
120
+ - 46 699 entities of the following [Unified Medical Language System (UMLS)](https://www.nlm.nih.gov/research/umls/index.html) semantic groups:
121
+ - ANAT (anatomy and body parts): 6728 entities
122
+ - CHEM (chemical and pharmacological substances): 9224 entities
123
+ - DISO (pathologic conditions): 13 067 entities
124
+ - PROC (therapeutic and diagnostic procedures, and laboratory analyses): 17 680 entities
125
+
126
+
127
+ ### Data Splits
128
+
129
+ - Train: 175 203 tokens, 28 101 entities
130
+ - Development: 58 670 tokens, 9629 entities
131
+ - Test: 58 300 tokens, 8969 entities
132
+
133
+ ## Dataset Creation
134
+
135
+ ### Source Data
136
+
137
+ - Abstracts from journals published under a Creative Commons license, available in [PubMed](https://pubmed.ncbi.nlm.nih.gov/) or the [Scientific Electronic Library Online (SciELO)](https://scielo.org/es/)
138
+ - Clinical trials announcements published in the [European Clinical Trials Register](https://www.clinicaltrialsregister.eu) and [Repositorio Español de Estudios Clínicos](https://reec.aemps.es)
139
+
140
+
141
+ ### Annotations
142
+
143
+ #### Who are the annotators?
144
+
145
+ - Leonardo Campillos-Llanos, Computational Linguist, Consejo Superior de Investigaciones Científicas
146
+ - Adrián Capllonch-Carrión, Medical Doctor, Centro de Salud Retiro, Hospital Universitario Gregorio Marañón
147
+ - Ana Valverde-Mateos, Medical Lexicographer, Spanish Royal Academy of Medicine
148
+
149
+ ## Considerations for Using the Data
150
+
151
+ **Disclosure**: This dataset is under development and needs to be improved. It should not be used for medical decision making without human assistance and supervision.
152
+
153
+ This resource is intended for a generalist purpose, and may have bias and/or any other undesirable distortions.
154
+
155
+ The owner or creator of the models will in no event be liable for any results arising from the use made by third parties of this dataset.
156
+
157
+ **Descargo de responsabilidad**: Este conjunto de datos se encuentra en desarrollo y no debe ser empleada para la toma de decisiones médicas
158
+
159
+ La finalidad de este modelo es generalista, y puede tener sesgos y/u otro tipo de distorsiones indeseables.
160
+
161
+ El propietario o creador de los modelos de ningún modo será responsable de los resultados derivados del uso que las terceras partes hagan de estos datos.